Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CRISPR Therapeutics announced that it will present Phase 1 clinical data for its investigational CAR T cell therapy, zugocabtagene geleucel (zugo-cel), in autoimmune disease at the American College of Rheumatology (ACR) Convergence 2026.
The company said it will present clinical data on zugocabtagene geleucel (Zugo-cel) in autoimmune disease at the American College of Rheumatology Convergence 2026.